saphnelo
astrazeneca ab - anifrolumab - lupus erythematosus, systemaattinen - immunosuppressantit - saphnelo is indicated as an add-on therapy for the treatment of adult patients with moderate to severe, active autoantibody-positive systemic lupus erythematosus (sle), despite standard therapy.
vydura
pfizer europe ma eeig - rimegepant - migreenihäiriöt - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
fluvosol 50 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - fluvoxamine maleate - tabletti, kalvopäällysteinen - 50 mg - fluvoksamiini
fluvosol 100 mg tabletti, kalvopäällysteinen
stada arzneimittel ag - fluvoxamine maleate - tabletti, kalvopäällysteinen - 100 mg - fluvoksamiini
topiramat ratiopharm 25 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - topiramate - tabletti, kalvopäällysteinen - 25 mg - topiramaatti
topiramat ratiopharm 50 mg tabletti, kalvopäällysteinen
ratiopharm gmbh - topiramate - tabletti, kalvopäällysteinen - 50 mg - topiramaatti
topiramat sandoz 15 mg kapseli, kova
sandoz a/s sandoz a/s - topiramatum - kapseli, kova - 15 mg - topiramaatti
zonisamide stada 25 mg kapseli, kova
stada arzneimittel ag stada arzneimittel ag - zonisamidum - kapseli, kova - 25 mg - tsonisamidi
lovastatin ratiopharm 20 mg tabletti
ratiopharm gmbh - lovastatinum - tabletti - 20 mg - lovastatiini
lovastatin ratiopharm 40 mg tabletti
ratiopharm gmbh - lovastatinum - tabletti - 40 mg - lovastatiini